Brief report: The uridine diphosphate glucuronosyltransferase 2B15 D 85Y and 2B17 deletion polymorphisms predict the glucuronidation pattern of androgens and fat mass in men

Journal of Clinical Endocrinology and Metabolism

Volumn 92, Issue 12, 2007, Pages 4878-4882

  Swanson, Charlotte ^a   Mellström, Dan ^a   Lorentzon, Mattias ^a   Vandenput, Liesbeth ^a   Jakobsson, Jenny ^b   Rane, Anders ^b   Karlsson, Magnus ^c,d   Ljunggren, Östen ^e   Smith, Ulf ^a   Eriksson, Anna Lena ^a   Bélanger, Alain ^f   Labrie, Fernand ^f   Ohlsson, Claes ^a,g  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c LUND UNIVERSITY   (Sweden)

^d LUND UNIVERSITY HOSPITAL   (Sweden)

^e UPPSALA UNIVERSITY   (Sweden)

^f LAVAL UNIVERSITY   (Canada)

^g SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; ANDROSTANEDIOL; ANDROSTANEDIOL 17 GLUCURONIDE; ANDROSTERONE GLUCURONIDE; FAT; GLUCURONIDE; GLUCURONOSYLTRANSFERASE; UNCLASSIFIED DRUG; URIDINE DIPHOSPHATE GLUCURONOSYLTRANSFERASE 2B15; URIDINE DIPHOSPHATE GLUCURONOSYLTRANSFERASE 2B17; INSULIN; SEX HORMONE; SEX HORMONE BINDING GLOBULIN;

ADULT; AGED; ANDROGEN BLOOD LEVEL; ARTICLE; BODY COMPOSITION; BODY MASS; CLINICAL ASSESSMENT; COHORT ANALYSIS; CONTROLLED STUDY; DUAL ENERGY X RAY ABSORPTIOMETRY; GAS CHROMATOGRAPHY; GENE DELETION; GENETIC POLYMORPHISM; GLUCURONIDATION; HOMEOSTASIS; HORMONE URINE LEVEL; HUMAN; HUMAN EXPERIMENT; INSULIN SENSITIVITY; LIQUID CHROMATOGRAPHY; MALE; MASS SPECTROMETRY; POPULATION RESEARCH; PREDICTION; PRIORITY JOURNAL; TANDEM MASS SPECTROMETRY; TESTOSTERONE BLOOD LEVEL; ADOLESCENT; AGING; BLOOD; GENETICS; GLUCOSE BLOOD LEVEL; INSULIN RESISTANCE; METABOLISM; OBESITY; PHOTON ABSORPTIOMETRY; PHYSIOLOGY; URINE;

ABSORPTIOMETRY, PHOTON; ADIPOSITY; ADOLESCENT; ADULT; AGED; AGING; ANDROGENS; BLOOD GLUCOSE; BODY COMPOSITION; GENE DELETION; GLUCURONIDES; GLUCURONOSYLTRANSFERASE; GONADAL STEROID HORMONES; HUMANS; INSULIN; INSULIN RESISTANCE; MALE; POLYMORPHISM, GENETIC; SEX HORMONE-BINDING GLOBULIN;

EID: 36849091940     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2007-0359     Document Type: Article

References (16)

1. Labrie F, Dupont A, Belanger A 1985 Complete androgen blockade for the treatment of prostate cancer. In: de Vita VT, Hellman S, Rosenberg SA, eds. Important advances in oncology. Philadelphia: JB Lippincott; 193-217
2. Belanger A, Pelletier G, Labrie F, Barbier O, Chouinard S 2003 Inactivation of androgens by UDP-glucuronosyltransferase enzymes in humans. Trends Endocrinol Metab 14:473-479
3. Labrie F, Luu-The V, Labrie C, Belanger A, Simard J, Lin SX, Pelletier G 2003 Endocrine and intracrine sources of androgens in women: inhibition of breast cancer and other roles of androgens and their precursor dehydroepiandrosterone. Endocr Rev 24:152-182
4. Levesque E, Beaulieu M, Green MD, Tephly TR, Belanger A, Hum DW 1997 Isolation and characterization of UGT2B15(Y85): a UDP- glucuronosyltransferase encoded by a polymorphic gene. Pharmacogenetics 7:317-325
5. Wilson 3rd W, Pardo-Manuel de Villena F, Lyn-Cook BD, Chatterjee PK, Bell TA, Detwiler DA, Gilmore RC, Valladeras IC, Wright CC, Threadgill DW, Grant DJ 2004 Characterization of a common deletion polymorphism of the UGT2B17 gene linked to UGT2B15. Genomics 84:707-714
6. Murata M, Warren EH, Riddell SR 2003 A human minor histocompatibility antigen resulting from differential expression due to a gene deletion. J Exp Med 197:1279-1289
7. Lorentzon M, Swanson C, Andersson N, Mellstrom D, Ohlsson C 2005 Free testosterone is a positive, whereas free estradiol is a negative, predictor of cortical bone size in young Swedish men: the GOOD study. J Bone Miner Res 20:1334-1341
8. Mellstrom D, Johnell O, Ljunggren O, Eriksson AL, Lorentzon M, Mallmin H, Holmberg A, Redlund-Johnell I, Orwoll E, Ohlsson C 2006 Free testosterone is an independent predictor of BMD and prevalent fractures in elderly men: MrOS Sweden. J Bone Miner Res 21:529-535
9. Labrie F, Belanger A, Belanger P, Berube R, Martel C, Cusan L, Gomez J, Candas B, Castiel I, Chaussade V, Deloche C, Leclaire J 2006 Androgen glucuronides, instead of testosterone, as the new markers of androgenic activity in women. J Steroid Biochem Mol Biol 99:182-188
10. Vandenput L, Labrie F, Mellstrom D, Swanson C, Knutsson T, Peeker R, Ljunggren O, Orwoll E, Eriksson AL, Damber JE, Ohlsson C 2007 Serum levels of specific glucuronidated androgen metabolites predict BMD and prostate volume in elderly men. J Bone Miner Res 22:220-227
11. Chung BC, Choo HY, Kim TW, Eom KD, Kwon OS, Suh J, Yang J, Park J 1990 Analysis of anabolic steroids using GC/MS with selected ion monitoring. J Anal Toxicol 14:91-95
12. Garle M, Ocka R, Palonek E, Bjorkhem I 1996 Increased urinary testosterone/epitestosterone ratios found in Swedish athletes in connection with a national control program. Evaluation of 28 cases. J Chromatogr B Biomed Appl 687:55-59
13. Jakobsson J, Ekstrom L, Inotsume N, Garle M, Lorentzon M, Ohlsson C, Roh HK, Carlstrom K, Rane A 2006 Large differences in testosterone excretion in Korean and Swedish men are strongly associated with a UDP-glucuronosyl transferase 2B17 polymorphism. J Clin Endocrinol Metab 91:687-693
14. Turgeon D, Carrier JS, Levesque E, Hum DW, Belanger A 2001 Relative enzymatic activity, protein stability, and tissue distribution of human steroid-metabolizing UGT2B subfamily members. Endocrinology 142:778-787
15. Beaulieu M, Levesque E, Hum DW, Belanger A 1996 Isolation and characterization of a novel cDNA encoding a human UDP-glucuronosyltransferase active on C19 steroids. J Biol Chem 271:22855-22862
16. Tchernof A, Levesque E, Beaulieu M, Couture P, Despres JP, Hum DW, Belanger A 1999 Expression of the androgen metabolizing enzyme UGT2B15 in adipose tissue and relative expression measurement using a competitive RT-PCR method. Clin Endocrinol (Oxf) 50:637-642